Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CROWN CORONATION: MR/MMR Vaccine for COVID-19 Prevention
NCT04333732Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2020
- Primary completion
- Aug 2021
- Modality
- Live Attenuated Vaccines
- Countries
- 5
01
Overview
A Phase 3 trial of M-M-R II in coronavirus disease 2019 (COVID-19), sponsored by Washington University School of Medicine. Started Sep 2020; status: completed.
02
Drugs
M-M-R II
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04333732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04333732.